BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25323857)

  • 1. Circulating CD34+ progenitor cells and risk of mortality in a population with coronary artery disease.
    Patel RS; Li Q; Ghasemzadeh N; Eapen DJ; Moss LD; Janjua AU; Manocha P; Kassem HA; Veledar E; Samady H; Taylor WR; Zafari AM; Sperling L; Vaccarino V; Waller EK; Quyyumi AA
    Circ Res; 2015 Jan; 116(2):289-297. PubMed ID: 25323857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex Differences in Circulating Progenitor Cells.
    Topel ML; Hayek SS; Ko YA; Sandesara PB; Samman Tahhan A; Hesaroieh I; Mahar E; Martin GS; Waller EK; Quyyumi AA
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28974500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Change in Circulating Progenitor Cells During Exercise Stress and Risk of Adverse Cardiovascular Events in Patients With Coronary Artery Disease.
    Moazzami K; Lima BB; Hammadah M; Ramadan R; Al Mheid I; Kim JH; Alkhoder A; Obideen M; Levantsevych O; Shah A; Liu C; Bremner JD; Kutner M; Sun YV; Waller EK; Hesaroieh IG; Raggi P; Vaccarino V; Quyyumi AA
    JAMA Cardiol; 2020 Feb; 5(2):147-155. PubMed ID: 31799987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progenitor Cells and Clinical Outcomes in Patients With Acute Coronary Syndromes.
    Samman Tahhan A; Hammadah M; Raad M; Almuwaqqat Z; Alkhoder A; Sandesara PB; Mohamed-Kelli H; Hayek SS; Kim JH; O'Neal WT; Topel ML; Grant AJ; Sabbak N; Heinl RE; Gafeer MM; Obideen M; Kaseer B; Abdelhadi N; Ko YA; Liu C; Hesaroieh I; Mahar EA; Vaccarino V; Waller EK; Quyyumi AA
    Circ Res; 2018 May; 122(11):1565-1575. PubMed ID: 29514830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating progenitor cells and outcomes in patients with coronary artery disease.
    Dhindsa DS; Desai SR; Jin Q; Sandesara PB; Mehta A; Liu C; Tahhan AS; Nayak A; Ejaz K; Hooda A; Moazzami K; Islam SJ; Rogers SC; Almuwaqqat Z; Mokhtari A; Hesaroieh I; Ko YA; Sperling LS; Waller EK; Quyyumi AA
    Int J Cardiol; 2023 Feb; 373():7-16. PubMed ID: 36460208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations Between Inflammation, Cardiovascular Regenerative Capacity, and Cardiovascular Events: A Cohort Study.
    Almuwaqqat Z; Hwan Kim J; Garcia M; Ko YA; Moazzami K; Lima B; Sullivan S; Alkhalaf J; Mehta A; Shah AJ; Hussain MS; Pearce BD; Bremner JD; Waller EK; Vaccarino V; Quyyumi AA
    Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2814-2822. PubMed ID: 34551591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progenitor Cells and Clinical Outcomes in Patients With Heart Failure.
    Samman Tahhan A; Hammadah M; Sandesara PB; Hayek SS; Kalogeropoulos AP; Alkhoder A; Mohamed Kelli H; Topel M; Ghasemzadeh N; Chivukula K; Ko YA; Aida H; Hesaroieh I; Mahar E; Kim JH; Wilson P; Shaw L; Vaccarino V; Waller EK; Quyyumi AA
    Circ Heart Fail; 2017 Aug; 10(8):. PubMed ID: 28790053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial progenitor cells, atheroma burden and clinical outcome in patients with coronary artery disease.
    Padfield GJ; Tura-Ceide O; Freyer E; Barclay GR; Turner M; Newby DE; Mills NL
    Heart; 2013 Jun; 99(11):791-8. PubMed ID: 23390050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow resident and circulating progenitor cells in patients undergoing cardiac surgery.
    Dotsenko O; Xiao Q; Xu Q; Jahangiri M
    Ann Thorac Surg; 2010 Dec; 90(6):1944-51. PubMed ID: 21095342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol.
    Schmidt-Lucke C; Fichtlscherer S; Aicher A; Tschöpe C; Schultheiss HP; Zeiher AM; Dimmeler S
    PLoS One; 2010 Nov; 5(11):e13790. PubMed ID: 21072182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating CD34+ cell subsets in patients with coronary endothelial dysfunction.
    Boilson BA; Kiernan TJ; Harbuzariu A; Nelson RE; Lerman A; Simari RD
    Nat Clin Pract Cardiovasc Med; 2008 Aug; 5(8):489-96. PubMed ID: 18578002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Progenitor Cells and Racial Differences.
    Samman Tahhan A; Hammadah M; Kelli HM; Kim JH; Sandesara PB; Alkhoder A; Kaseer B; Gafeer MM; Topel M; Hayek SS; O'Neal WT; Obideen M; Ko YA; Liu C; Hesaroieh I; Mahar E; Vaccarino V; Waller EK; Quyyumi AA
    Circ Res; 2018 Aug; 123(4):467-476. PubMed ID: 29930146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Progenitor Cells Identify Peripheral Arterial Disease in Patients With Coronary Artery Disease.
    Hayek SS; MacNamara J; Tahhan AS; Awad M; Yadalam A; Ko YA; Healy S; Hesaroieh I; Ahmed H; Gray B; Sher SS; Ghasemzadeh N; Patel R; Kim J; Waller EK; Quyyumi AA
    Circ Res; 2016 Aug; 119(4):564-71. PubMed ID: 27267067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of enhanced external counterpulsation on circulating CD34+ progenitor cell subsets.
    Kiernan TJ; Boilson BA; Tesmer L; Harbuzariu A; Simari RD; Barsness GW
    Int J Cardiol; 2011 Dec; 153(2):202-6. PubMed ID: 20843569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse correlation between circulating endothelial progenitor cells with CD34+CD133+ and the severity of coronary atherosclerosis assessed by Syntax score.
    Chi J; Hong X; Wang Y; Zhao J; Yang W
    Am J Med Sci; 2014 Jun; 347(6):457-62. PubMed ID: 24335569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteocalcin positive CD133+/CD34-/KDR+ progenitor cells as an independent marker for unstable atherosclerosis.
    Flammer AJ; Gössl M; Widmer RJ; Reriani M; Lennon R; Loeffler D; Shonyo S; Simari RD; Lerman LO; Khosla S; Lerman A
    Eur Heart J; 2012 Dec; 33(23):2963-9. PubMed ID: 22855739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis.
    Gössl M; Mödder UI; Atkinson EJ; Lerman A; Khosla S
    J Am Coll Cardiol; 2008 Oct; 52(16):1314-25. PubMed ID: 18929243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remote ischemic preconditioning immediately before percutaneous coronary intervention does not impact myocardial necrosis, inflammatory response, and circulating endothelial progenitor cell counts: a single center randomized sham controlled trial.
    Prasad A; Gössl M; Hoyt J; Lennon RJ; Polk L; Simari R; Holmes DR; Rihal CS; Lerman A
    Catheter Cardiovasc Interv; 2013 May; 81(6):930-6. PubMed ID: 22517646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age and Human Regenerative Capacity Impact of Cardiovascular Risk Factors.
    Al Mheid I; Hayek SS; Ko YA; Akbik F; Li Q; Ghasemzadeh N; Martin GS; Long Q; Hammadah M; Maziar Zafari A; Vaccarino V; Waller EK; Quyyumi AA
    Circ Res; 2016 Sep; 119(7):801-9. PubMed ID: 27436845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Prediction of Cardiovascular Outcomes by Circulating CD34+ and CD34+CD133+ Stem Cells in Patients With Type 2 Diabetes.
    Fadini GP; Rigato M; Cappellari R; Bonora BM; Avogaro A
    Diabetes Care; 2017 Jan; 40(1):125-131. PubMed ID: 27815289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.